Entries by Cristina

Exactmer joins forces with leading institutions to secure Innovative Technologies Award

Exactmer is excited to announce the successful application to the Innovative Technologies for Nucleic Acid Medicines Manufacturing competition, delivered by the Innovate UK Transforming Medicine Manufacturing programme. Exactmer will work in collaboration with CPI, Queen Mary University of London and AstraZeneca, forming a consortium of leading experts in membrane production, nanofiltration, oligo manufacture and commercialisation.  […]

Exactmer Awarded £2M for Alternative Oligo Chemistries

Exactmer is delighted to announce it has been awarded €2.49M (£2.15M) from the European Innovation Council (EIC) through its Transition programme, to fund ground-breaking research in the synthesis and manufacture of oligonucleotide (oligo) therapeutics. The funding will fast-track the development of new oligo chemistries for Exactmer’s patented Nanostar Sieving technology, which enables the large-scale manufacture […]

Exactmer awarded with SMART Grant from Innovate UK

Exactmer is pleased to announce that it has been awarded a SMART Grant from Innovate UK. Innovate UK drives productivity and economic growth by supporting businesses to develop and harness the potential of new ideas. Through this 16-month long project, due to start later this year, Exactmer will develop a disruptive new approach for the […]

New Facilities

Exactmer is excited to announce the opening of new facilities at our premises in the Londoneast-UK Business and Technical Park in Dagenham, East London. The new space will house a Membrane Casting facility, for the manufacture and production of proprietary membranes used in our Nanostar Sieving platform. The facility will also accommodate membrane-related R&D activities. […]

Exactmer awarded Knowledge Transfer Partnership with Queen Mary University of London

Exactmer, together with Queen Mary University of London (QMUL), has been awarded its first Knowledge Transfer Partnership (KTP), from Innovate UK. Through this KTP, Exactmer and QMUL will develop new synthesis methods for exact Polyethylene Glycol polymers (PEGs), using Exactmer’s proprietary Nanostar Sieving platform. When added to therapeutics drugs, PEGs help to regulate the transport […]

Exactmer wins Startup Pitch and Partner Award at BioVaria, Munich

Exactmer is delighted to have been awarded the Startup Pitch and Partner award in the ‘Emerging’ category, at BioVaria 2022. Exactmer’s winning pitch on the development of our proprietary Nanostar Sieving technology for oligonucleotide synthesis was chosen by a jury of leading investors, in a showcase of 13 hand-picked start ups from across Europe. BioVaria […]

Future Leaders Fellowships granted to Dr. Jiang in collaboration with Exactmer for the development of breakthrough technology

Exactmer is excited to announce that Dr. Zhiwei Jiang has been selected as one of eighty-four of the most promising science and research leaders, the successful leaders will benefit from a total of £97.8m investment to tackle major global challenges and to commercialise innovations in the UK. The Future Leaders Fellowships scheme helps universities and […]

Accelerating Your Innovation Through Powerful Partnering

The SCOUT project, launched by CPI to help Scottish SMEs overcome challenges of innovation, hosted a webinar on February 9th 2022, centred on ‘Powerful Partnering’. At this event, Andrew Livingston outlined Exactmer’s journey and the successful partnership that supported its development. In 2021, Exactmer became a central part of Grand Challenge 3, from the new […]

Alnylam becomes a partner in the Medicines Manufacturing Innovation Centre

Exactmer is delighted to welcome to Alnylam Pharmaceuticals as a partner to the collaboration with the Medicines Manufacturing Innovation Centre, revolutionising oligonucleotide manufacturing. Together with CPI, AstraZeneca, and Novartis, we’re working together to overcome barriers to the scalable, affordable, and sustainable manufacture of oligonucleotides. See the full press release on the CPI website.  

Transforming Oligonucleotide Manufactuing

In the latest issue of Chemistry Today, Andrew Livingston and Katie Murray discuss the challenges involved with oligonucleotide manufacturing, and the role Nanostar Sieving can play in overcoming them. Abstract Oligonucleotides, which have already shown success in the treatment of rare diseases, are now being used to treat conditions with much larger patient populations. However, […]